GENETICALLY ENGINEERED REAGENTS

Brand Owner (click to sort) Address Description
BIOSOURCE ANTIGENICS BIOSOURCE TECHNOLOGIES, INC. 3333 Vaca Valley Parkway, Suite 1000 Vacaville CA 95688 GENETICALLY ENGINEERED REAGENTS, NAMELY PROTEIN FOR MEDICAL USE, CELLS CONTAINING GENETICALLY ENGINEERED PROTEIN MOLECULES FOR MEDICAL USE AND BIOCHEMICALS, NAMELY GENETICALLY ENGINEERED PROTEIN MOLECULES;DNA, RNA MOLECULES OR PEPTIDES INCORPORATING A PARTICULAR GENE OR GENES OF INTEREST FOR SCIENTIFIC USE;ANTIGENICS;BIOLOGICAL AND GENETIC RESEARCH SERVICES;
BIOSOURCE PROTEOMICS BIOSOURCE TECHNOLOGIES, INC. 3333 Vaca Valley Parkway, Suite 1000 Vacaville CA 95688 GENETICALLY ENGINEERED REAGENTS, NAMELY, PROTEIN FOR MEDICAL USE, CELLS CONTAINING GENETICALLY ENGINEERED PROTEIN MOLECULES FOR MEDICAL USE AND BIOCHEMICALS, NAMELY, GENETICALLY ENGINEERED PROTEIN MOLECULES FOR MEDICAL USE;BIO SOURCE PROTEOMICS;GENETICALLY ENGINEERED REAGENTS, NAMELY, PROTEIN FOR SCIENTIFIC RESEARCH, CELLS CONTAINING GENETICALLY ENGINEERED PROTEIN MOLECULES FOR SCIENTIFIC RESEARCH AND BIOCHEMICALS, NAMELY GENETICALLY ENGINEERED PROTEIN MOLECULES FOR SCIENTIFIC RESEARCH;PROTEOMICS;SCIENTIFIC RESEARCH, NAMELY, BIOLOGICAL AND PROTEIN RESEARCH;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is based upon a surprising finding that stem cells, more particularly neural stem cells, can migrate throughout a brain tumor and track metastatic brain tumor cells. The invention provides a method for treating brain tumors by administering genetically engineered neural stem cells in an individual affected by brain tumors. The invention also provides a method of preparing genetically engineered neural stem cells and a composition comprising genetically engineered neural stem cells in a pharmaceutically acceptable carrier.